Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Shun Doi"'
Autor:
Masao Nakajima, Shoichi Hazama, Yukio Tokumitsu, Yoshitaro Shindo, Hiroto Matsui, Satoshi Matsukuma, Yuki Nakagami, Koji Tamada, Keiko Udaka, Michiie Sakamoto, Akira Saito, Yasunari Kouki, Toshinari Uematsu, Ming Xu, Michihisa Iida, Ryouichi Tsunedomi, Nobuaki Suzuki, Shigeru Takeda, Tatsuya Ioka, Shun Doi, Hiroaki Nagano
Publikováno v:
Hepatology Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28dba7d789f85d9d2319cad53c0e5994
https://doi.org/10.1111/hepr.13900
https://doi.org/10.1111/hepr.13900
Autor:
Shin Yoshida, Akira Saito, Nobuaki Suzuki, Yuki Nakagami, Hiroto Matsui, Koji Tamada, Michihisa Iida, Hiroaki Nagano, Masao Nakajima, Shigefumi Yoshino, Shigeru Takeda, Toshinari Uematsu, Hideki Arima, Yasunobu Kouki, Tomio Ueno, Satoshi Matsukuma, Shinobu Tomochika, Shigeru Yamamoto, Shun Doi, Keiko Udaka, Yoshitaro Shindo, Yukio Tokumitsu, Shoichi Hazama, Shinsuke Kanekiyo
Publikováno v:
Cancer Immunology, Immunotherapy
Background This phase I study aimed to evaluate the safety, peptide-specific immune responses, and anti-tumor effects of a novel vaccination therapy comprising multi-HLA-binding heat shock protein (HSP) 70/glypican-3 (GPC3) peptides and a novel adjuv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3358c62af886f5e7f7eb7ad31a5766c7
https://doi.org/10.1007/s00262-020-02518-7
https://doi.org/10.1007/s00262-020-02518-7
Autor:
Tomio Ueno, Shigeru Takeda, Yasuharu Nishimura, Shoichi Hazama, Shinobu Tomochika, Atsushi Irie, Tomoya Miyakawa, Yukio Tokumitsu, Masao Nakajima, Hiroaki Nagano, Shigeru Yamamoto, Shin Yoshida, Shun Doi, Nobuaki Suzuki, Shinsuke Kanekiyo, Koji Tamada, Hiroto Matsui, Yoshitaro Shindo, Keiko Udaka, Michihisa Iida, Shigefumi Yoshino
Publikováno v:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
Supplemental Digital Content is available in the text.
We previously found that heat-shock protein 70 (HSP70) is expressed on hepatocellular carcinoma cells and developed an HSP70 mRNA-transfected dendritic cell therapy for treating unresectable
We previously found that heat-shock protein 70 (HSP70) is expressed on hepatocellular carcinoma cells and developed an HSP70 mRNA-transfected dendritic cell therapy for treating unresectable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44161fa9a79afe6a245e6c7ad8250daf
https://pubmed.ncbi.nlm.nih.gov/31398179
https://pubmed.ncbi.nlm.nih.gov/31398179
Autor:
Shoichi Hazama, Tomoya Miyakawa, Koji Tamada, Takahiro Iguchi, Yukimi Sakoda, Keishi Adachi, Hiroto Matsui, Shun Doi, Yosuke Kano, Hiroaki Nagano, Yoshiya Ueyama
Publikováno v:
Cancer Science
Therapeutic cancer vaccines are designed to treat cancer by boosting the endogenous immune system to fight against the cancer. In the development of clinically effective cancer vaccines, one of the most practical objectives is to identify adjuvants t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe6e875804a6608166d6eb158ae734ad
http://europepmc.org/articles/PMC4832865
http://europepmc.org/articles/PMC4832865
Autor:
Hiroto Matsui, Shiro Akinaga, Satoshi Matsukuma, Yoshitaro Shindo, Akira Saito, Nobuaki Suzuki, Shigeru Takeda, Michihisa Iida, Masao Nakajima, Yuki Nakagami, Shun Doi, Yukio Tokumitsu, Shin Yoshida, Keiko Udaka, Koji Tamada, Ryouichi Tsunedomi, Hiroaki Nagano, Michiie Sakamoto, Shinobu Tomochika, Shoichi Hazama
Publikováno v:
Cancer Research. 80:CT251-CT251
Background: Even with curative resection, the recurrence rate of HCC remains high, and effective adjuvant therapies are not currently available. Our previous Phase I study with novel therapeutic peptides and immune adjuvants demonstrated safety, anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0994e7d20d8d7c8587194f73be8b629
https://doi.org/10.1158/1538-7445.am2020-ct251
https://doi.org/10.1158/1538-7445.am2020-ct251
Autor:
Nobuaki Suzuki, Toshinari Uematsu, Yuki Nakagami, Koji Tamada, Shigefumi Yoshino, Michihisa Iida, Shinsuke Kanekiyo, Yoshitaro Shindo, Shinobu Tomochika, Shoichi Hazama, Shun Doi, Yukio Tokumitsu, Keiko Udaka, Hiroaki Nagano, Yasunari Koki, Tomio Ueno, Hiroto Matsui, Shiro Akinaga, Shigeru Takeda, Shin Yoshida
Publikováno v:
Journal of Clinical Oncology. 37:e14306-e14306
e14306 Background: Even with curative resection, the recurrence rate of HCC is still high, and no effective adjuvant therapy is currently available. Our previous Phase I study with novel therapeutic peptides and immune adjuvants demonstrated the safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96a002d45ee6063bae92a50621b60ad3
https://doi.org/10.1200/jco.2019.37.15_suppl.e14306
https://doi.org/10.1200/jco.2019.37.15_suppl.e14306
Publikováno v:
Choonpa Igaku. 39:305-315
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1faf810292808cedb1057d9a7d95145
https://doi.org/10.3179/jjmu.39.305
https://doi.org/10.3179/jjmu.39.305
Autor:
Yukio Tokumitsu, Koji Tamada, Tomoya Miyakawa, Kazuhiko Sakamoto, Tomomitsu Satoh, Nobuaki Suzuki, Shigeru Yamamoto, Hideki Arima, Shinsuke Kanekiyo, Tomio Ueno, Toshinari Uematsu, Shigeru Takeda, Shoichi Hazama, Shigefumi Yoshino, Keiko Udaka, Hiroto Matsui, Hiroaki Nagano, Yasunari Koki, Shun Doi
Publikováno v:
Journal of Clinical Oncology. 36:e15167-e15167
e15167Background: Based on the exploratory analysis of our previous studies of peptide vaccine, we concluded that the combination of adjuvants hLAG-3Ig + Poly-ICLC is essential for controlling nega...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7485406d6d77df3c567cde87749fd00b
https://doi.org/10.1200/jco.2018.36.15_suppl.e15167
https://doi.org/10.1200/jco.2018.36.15_suppl.e15167
Autor:
Shun Doi, Yasunari Koki, Masahiro Kitahara, Toshinari Uematsu, Hideki Arima, Hiroto Matsui, Yoshihiro Tokuhisa, Shigefumi Yoshino, Kazuhiko Sakamoto, Keiko Udaka, Shigeru Takeda, Koji Tamada, Shoichi Hazama, Shigeru Yamamoto, Hiroyuki Furukawa, Shinsuke Kanekiyo, Tomoya Miyakawa, Nobuaki Suzuki, Yukio Tokumitsu, Hiroaki Nagano
Publikováno v:
Journal of Clinical Oncology. 35:3086-3086
3086 Background: Based on the exploratory analysis of our previous studies of peptide vaccine, we concluded that the combination of adjuvants hLAG-3Ig + Poly-ICLC is essential for controlling negative immune checkpoints and enhancing the induction of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d5b31406f0b75b14002af794a469583
https://doi.org/10.1200/jco.2017.35.15_suppl.3086
https://doi.org/10.1200/jco.2017.35.15_suppl.3086
Publikováno v:
Journal of the Visualization Society of Japan. 20:115-118
We have developed a concurrent visualization system RVSLIB (Real-time Visual Simulation Library). This paper shows the effectiveness of the system when it is applied to large-scale unsteady simulations, for which the conventional post-processing appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3b88bace1f4fee022019f0484f69f78
https://doi.org/10.3154/jvs.20.1supplement_115
https://doi.org/10.3154/jvs.20.1supplement_115